cilostazol has been researched along with D-fructopyranose in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, Y; Hara, T; Hotta, N; Inukai, S; Kasama, N; Koh, N; Mori, K; Nakamura, J; Nakashima, E; Sakakibara, F; Sasaki, H | 1 |
| Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK | 1 |
2 other study(ies) available for cilostazol and D-fructopyranose
| Article | Year |
|---|---|
Electroretinogram in sucrose-fed diabetic rats treated with an aldose reductase inhibitor or an anticoagulant.
Topics: 2,3-Diphosphoglycerate; Aldehyde Reductase; Animals; Anticoagulants; Blood Glucose; Body Weight; Cilostazol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Dietary Sucrose; Electroretinography; Enzyme Inhibitors; Fructose; Humans; Insulin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Retina; Sorbitol; Tetrazoles; Thiophenes; Triglycerides | 1997 |
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia.
Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Caffeine; Cilostazol; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Glycogen Synthase Kinase 3 beta; Rats | 2022 |